mRNA Synthesis and Manufacturing Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology  

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on MRNA Synthesis and Manufacturing Market 

5.1. COVID-19 Landscape: MRNA Synthesis and Manufacturing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global MRNA Synthesis and Manufacturing Market, By Product

8.1. MRNA Synthesis and Manufacturing Market Revenue and Volume, by Product

8.1.1. Drug Substance (APIs)

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Drug Product (Finished Formulations)       

8.1.2.1. Market Revenue and Volume Forecast

Chapter 9. Global MRNA Synthesis and Manufacturing Market, By Service

9.1. MRNA Synthesis and Manufacturing Market Revenue and Volume, by Service

9.1.1. GMP-Grade Manufacturing

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Custom mRNA Synthesis

9.1.2.1. Market Revenue and Volume Forecast

Chapter 10. Global MRNA Synthesis and Manufacturing Market, By Application 

10.1. MRNA Synthesis and Manufacturing Market Revenue and Volume, by Application

10.1.1. Vaccine Production

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Therapeutics (Oncology/Rare Disease)

10.1.2.1. Market Revenue and Volume Forecast

Chapter 11. Global MRNA Synthesis and Manufacturing Market, By Scale of Operation

11.1. MRNA Synthesis and Manufacturing Market Revenue and Volume, by Scale of Operation

11.1.1. Commercial Scale

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Preclinical/Clinical Scale

11.1.2.1. Market Revenue and Volume Forecast

Chapter 12. Global MRNA Synthesis and Manufacturing Market, By End-User

12.1. MRNA Synthesis and Manufacturing Market Revenue and Volume, by End-User

12.1.1. Pharmaceutical and Biotech Companies

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. CROs and CDMOs

12.1.2.1. Market Revenue and Volume Forecast

Chapter 13. Global MRNA Synthesis and Manufacturing Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product

13.1.2. Market Revenue and Volume Forecast, by Service

13.1.3. Market Revenue and Volume Forecast, by Application

13.1.4. Market Revenue and Volume Forecast, by Scale of Operation

13.1.5. Market Revenue and Volume Forecast, by End-User

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product

13.1.6.2. Market Revenue and Volume Forecast, by Service

13.1.6.3. Market Revenue and Volume Forecast, by Application

13.1.6.4. Market Revenue and Volume Forecast, by Scale of Operation

13.1.6.5. Market Revenue and Volume Forecast, by End-User  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product

13.1.7.2. Market Revenue and Volume Forecast, by Service

13.1.7.3. Market Revenue and Volume Forecast, by Application

13.1.7.4. Market Revenue and Volume Forecast, by Scale of Operation

13.1.7.5. Market Revenue and Volume Forecast, by End-User

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product

13.2.2. Market Revenue and Volume Forecast, by Service

13.2.3. Market Revenue and Volume Forecast, by Application

13.2.4. Market Revenue and Volume Forecast, by Scale of Operation  

13.2.5. Market Revenue and Volume Forecast, by End-User  

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product

13.2.6.2. Market Revenue and Volume Forecast, by Service

13.2.6.3. Market Revenue and Volume Forecast, by Application

13.2.7. Market Revenue and Volume Forecast, by Scale of Operation  

13.2.8. Market Revenue and Volume Forecast, by End-User  

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product

13.2.9.2. Market Revenue and Volume Forecast, by Service

13.2.9.3. Market Revenue and Volume Forecast, by Application

13.2.10. Market Revenue and Volume Forecast, by Scale of Operation

13.2.11. Market Revenue and Volume Forecast, by End-User

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product

13.2.12.2. Market Revenue and Volume Forecast, by Service

13.2.12.3. Market Revenue and Volume Forecast, by Application

13.2.12.4. Market Revenue and Volume Forecast, by Scale of Operation

13.2.13. Market Revenue and Volume Forecast, by End-User

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product

13.2.14.2. Market Revenue and Volume Forecast, by Service

13.2.14.3. Market Revenue and Volume Forecast, by Application

13.2.14.4. Market Revenue and Volume Forecast, by Scale of Operation

13.2.15. Market Revenue and Volume Forecast, by End-User

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product

13.3.2. Market Revenue and Volume Forecast, by Service

13.3.3. Market Revenue and Volume Forecast, by Application

13.3.4. Market Revenue and Volume Forecast, by Scale of Operation

13.3.5. Market Revenue and Volume Forecast, by End-User

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product

13.3.6.2. Market Revenue and Volume Forecast, by Service

13.3.6.3. Market Revenue and Volume Forecast, by Application

13.3.6.4. Market Revenue and Volume Forecast, by Scale of Operation

13.3.7. Market Revenue and Volume Forecast, by End-User

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product

13.3.8.2. Market Revenue and Volume Forecast, by Service

13.3.8.3. Market Revenue and Volume Forecast, by Application

13.3.8.4. Market Revenue and Volume Forecast, by Scale of Operation

13.3.9. Market Revenue and Volume Forecast, by End-User

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product

13.3.10.2. Market Revenue and Volume Forecast, by Service

13.3.10.3. Market Revenue and Volume Forecast, by Application

13.3.10.4. Market Revenue and Volume Forecast, by Scale of Operation

13.3.10.5. Market Revenue and Volume Forecast, by End-User

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product

13.3.11.2. Market Revenue and Volume Forecast, by Service

13.3.11.3. Market Revenue and Volume Forecast, by Application

13.3.11.4. Market Revenue and Volume Forecast, by Scale of Operation

13.3.11.5. Market Revenue and Volume Forecast, by End-User

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product

13.4.2. Market Revenue and Volume Forecast, by Service

13.4.3. Market Revenue and Volume Forecast, by Application

13.4.4. Market Revenue and Volume Forecast, by Scale of Operation

13.4.5. Market Revenue and Volume Forecast, by End-User

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product

13.4.6.2. Market Revenue and Volume Forecast, by Service

13.4.6.3. Market Revenue and Volume Forecast, by Application

13.4.6.4. Market Revenue and Volume Forecast, by Scale of Operation

13.4.7. Market Revenue and Volume Forecast, by End-User

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product

13.4.8.2. Market Revenue and Volume Forecast, by Service

13.4.8.3. Market Revenue and Volume Forecast, by Application

13.4.8.4. Market Revenue and Volume Forecast, by Scale of Operation

13.4.9. Market Revenue and Volume Forecast, by End-User

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product

13.4.10.2. Market Revenue and Volume Forecast, by Service

13.4.10.3. Market Revenue and Volume Forecast, by Application

13.4.10.4. Market Revenue and Volume Forecast, by Scale of Operation

13.4.10.5. Market Revenue and Volume Forecast, by End-User

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product

13.4.11.2. Market Revenue and Volume Forecast, by Service

13.4.11.3. Market Revenue and Volume Forecast, by Application

13.4.11.4. Market Revenue and Volume Forecast, by Scale of Operation

13.4.11.5. Market Revenue and Volume Forecast, by End-User

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product

13.5.2. Market Revenue and Volume Forecast, by Service

13.5.3. Market Revenue and Volume Forecast, by Application

13.5.4. Market Revenue and Volume Forecast, by Scale of Operation

13.5.5. Market Revenue and Volume Forecast, by End-User

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product

13.5.6.2. Market Revenue and Volume Forecast, by Service

13.5.6.3. Market Revenue and Volume Forecast, by Application

13.5.6.4. Market Revenue and Volume Forecast, by Scale of Operation

13.5.7. Market Revenue and Volume Forecast, by End-User

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product

13.5.8.2. Market Revenue and Volume Forecast, by Service

13.5.8.3. Market Revenue and Volume Forecast, by Application

13.5.8.4. Market Revenue and Volume Forecast, by Scale of Operation

13.5.8.5. Market Revenue and Volume Forecast, by End-User

Chapter 14. Company Profiles

14.1. Thermo Fisher Scientific Inc. 

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Danaher Corporation (Aldevron/IDT) 

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Maravai LifeSciences (TriLink BioTechnologies) 

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. BioNTech SE 

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. CureVac SE 

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. New England Biolabs 

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. New England Biolabs 

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. ST Pharm Co., Ltd. 

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. GenScript Biotech Corporation 

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Merck KGaA 

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms